Literature DB >> 21946070

Apocynin may limit total cell death following cerebral ischemia and reperfusion by enhancing apoptosis.

Barry J Connell1, Monique C Saleh, Bobby V Khan, Tarek M Saleh.   

Abstract

The present study was designed to determine a dose-response relationship between apocynin and infarct volume as well as to provide a possible molecular mechanism mediating this effect. We tested the hypothesis that apocynin protects against cell death following stroke and reperfusion injury. Apocynin was administered 30 min prior to, or immediately following removal of sutures used to occlude the middle cerebral artery (MCA) in male Sprague-Dawley rats. Following removal of the sutures, the MCA was allowed to undergo 5.5h of reperfusion. Pretreatment with apocynin 30 min prior to occlusion resulted in a dose-dependent reduction in infarct volume by ∼50 %. Analysis of tissue from the ischemic cortex of apocynin-treated rats showed an increase in the level of glutathione (GSH), protein adducts (HNE-His), hydrogen peroxide (H(2)O(2)) and DNA fragmentation (apoptotic cell death) was also observed. This suggests that apocynin may increase antioxidant defense systems (GSH) to limit the degree of ischemia-induced cellular stress. In addition, this moderate cell stress results in more apoptotic vs necrotic cell death, and thus may limit the spreading depression and total cell death that occurs following ischemia/reperfusion. These effects may serve as a potential novel mechanism of action contributing to the apocynin-induced neuroprotection observed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946070     DOI: 10.1016/j.fct.2011.09.010

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats.

Authors:  Ahmed F Soliman; Lobna M Anees; Doaa M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

Review 2.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

3.  Protective and therapeutic effect of apocynin on bleomycin-induced lung fibrosis in rats.

Authors:  Talat Kilic; Hakan Parlakpinar; Elif Taslidere; Sedat Yildiz; Alaadin Polat; Nigar Vardi; Cemil Colak; Hilal Ermis
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 4.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

5.  Increasing the Biological Stability Profile of a New Chemical Entity, UPEI-104, and Potential Use as a Neuroprotectant Against Reperfusion-Injury.

Authors:  Tarek M Saleh; Barry J Connell; Inan Kucukkaya; Alaa S Abd-El-Aziz
Journal:  Brain Sci       Date:  2015-04-21

6.  A stability-indicating high performance liquid chromatography method to determine apocynin in nanoparticles.

Authors:  Juliana Kovalczuk de Oliveira; Débora Fernanda Veres Ronik; Jociani Ascari; Rubiana Mara Mainardes; Najeh Maissar Khalil
Journal:  J Pharm Anal       Date:  2016-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.